Bafna Pharmaceuticals Intrinsic Value
BAFNAPH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹262.77 | ₹236.49 - ₹289.05 | +150.0% | Book Value/Share: ₹255.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹210.22 | ₹189.20 - ₹231.24 | +100.0% | Revenue/Share: ₹240.00, P/S: 2.0x |
Want to compare with current market value? Check BAFNAPH share price latest .
Valuation Comparison Chart
BAFNAPH Intrinsic Value Analysis
What is the intrinsic value of BAFNAPH?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Bafna Pharmaceuticals (BAFNAPH) is ₹262.77 (median value). With the current market price of ₹105.11, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹210.22 to ₹262.77, indicating ₹210.22 - ₹262.77.
Is BAFNAPH undervalued or overvalued?
Based on our multi-method analysis, Bafna Pharmaceuticals (BAFNAPH) appears to be trading below calculated value by approximately 150.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 12.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -7.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.68x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Bafna Pharmaceuticals
Additional stock information and data for BAFNAPH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2020 | ₹-34 Cr | ₹-34 Cr | Negative Cash Flow | 3/10 |
| March 2019 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2018 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2017 | ₹-1 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2016 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |